AbbVie Inc.

Company Overview

AbbVie Inc. is a major pharmaceutical company that offers immunology, hematologic oncology, neuroscience, aesthetics, and eye care products. AbbVie maintains an extensive immunology portfolio across rheumatology, dermatology, and gastroenterology. The company operates in over 70 countries and markets its products in over 175 countries.

AbbVie has more than 250 collaborations/partnerships with leading biotechnology companies, universities, nonprofits, and government organizations to advance science. The company specializes in monoclonal antibodies, antibody-drug conjugates, and multi-specific antibodies for antibody therapeutics.

Financial Highlights (FY 2024)

Company's Business Segments

• Immunology : Gastroenterology, Dermatology, Rheumatology, Innate immunity / interferon and TH2 mediated diseases, Select fibrotic conditions.
• Oncology : Novel and differentiated programs directed towards enhanced tumor cell targeting, oncogenic signaling pathways and immuno-oncology, Targeted biologics and next generation cell therapies, Novel approaches to small molecules, including technologies to address hard-to-drug target classes.
• Aesthetics : Dermal injectables for skin and tissue, Plastics and regenerative medicine, Toxins for aesthetic and therapeutics, Hair growth, Body contouring and fat reduction, Topical skin care.
• Neuroscience : Disease modification approaches for neurodegenerative diseases, including Alzheimer’s and Parkinson’s disease, and select diseases driven by shared biological pathways, Psychiatric diseases, including bipolar disorder, bipolar depression, major depressive disorder, generalized anxiety disorder and schizophrenia, Symptomatic approaches with clinical validation for cognitive and neurobehavioral deficits in Alzheimer’s and Parkinson’s disease, Migraine, Spasticity and movement disorders; neurorestoration in multiple sclerosis.
• Eye Care : Retinal degeneration, including Dry AMD/geographic atrophy, Wet AMD and diabetic retinal diseases, Dry eye and ocular surface disease of various etiologies, Glaucoma, addressing intraocular pressure control and neuroprotection, Refractive medicine, including presbyopia, myopia and corneal dystrophies.
• Other Key products : Virology, Cystic fibrosis, Women’s health, Platforms and technologies.